Literature DB >> 2825574

Immunological heterogeneity and cellular mechanisms in myasthenia gravis.

J Newsom-Davis1, N Willcox, M Schluep, G Harcourt, A Vincent, S Mossman, D Wray, J Burges.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2825574     DOI： 10.1111/j.1749-6632.1987.tb51279.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  14 in total

1.  Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity.

Authors:  A Demaine; N Willcox; M Janer; K Welsh; J Newsom-Davis
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

2.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

3.  The thymus in seronegative myasthenia gravis patients.

Authors:  N Willcox; M Schluep; M A Ritter; J Newsom-Davis
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

4.  Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.

Authors:  Natalie Tsinzerling; Ann-Kari Lefvert; Georg Matell; Ritva Pirskanen-Matell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

Review 5.  A practical guide to the recognition and management of myasthenia gravis.

Authors:  A Evoli; A P Batocchi; P Tonali
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

6.  Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.

Authors:  Florence Jambou; Wei Zhang; Monique Menestrier; Isabelle Klingel-Schmitt; Olivier Michel; Sophie Caillat-Zucman; Abderrahim Aissaoui; Ludovic Landemarre; Sonia Berrih-Aknin; Sylvia Cohen-Kaminsky
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.

Authors:  E Meinl; W E Klinkert; H Wekerle
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

8.  Familial autoimmune myasthenia gravis with different pathogenetic antibodies.

Authors:  C Provenzano; O Arancio; A Evoli; B Rocca; E Bartoccioni; D de Grandis; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

Review 9.  Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.

Authors:  J E Merrill; M C Graves; D G Mulder
Journal:  West J Med       Date:  1992-06

10.  Metaplastic thymoma with myasthenia gravis presumably caused by an accumulation of intratumoral immature T cells: a case report.

Authors:  Shogo Tajima; Masahiro Yanagiya; Masaaki Sato; Jun Nakajima; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.